A kind of hydroxyapatite microsphere and its preparation method and application

By using specific chelating agents and adjusting reaction conditions in hydrothermal reactions, porous hydroxyapatite microspheres with morphology can be prepared, which solves the problem of difficulty in adjusting particle size and pore structure in the prior art, and realizes microspheres fine regulation and effective application of regenerated filler materials.

CN118206089BActive Publication Date: 2024-11-26SHANGHAI BEERKANG BIOMEDICAL TECH CO LTD
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410320397.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-20
Publication Date
2024-11-26
Estimated Expiration
2044-03-20

AI Technical Summary

Technical Problem

The prior art is difficult to obtain porous hydroxyapatite microspheres with adjustable morphology, especially in hydrothermal synthesis, and it is difficult to adjust the particle size and pore structure, and it is difficult to realize the nano self-assembly structure.

Method used

By using specific chelating agents in hydrothermal reactions, such as glutamic acid, disodium ethylenediaminetetraacetate, sodium citrate, etc., the pH value of the reaction solution is adjusted and the temperature and reaction time is controlled to prepare a morphologically adjustable one. Hydroxyapatite microspheres, the method includes dissolving chelating agent, calcium source, phosphorus source and urea in water, adjusting the pH to 1.00-4.00, carrying out a hydrothermal reaction of 90-250°C, and then collecting the precipitate and drying to obtain Porous hydroxyapatite microspheres.

Benefits of technology

The fine regulation of the particle size and pore size of hydroxyapatite microspheres is achieved, which can effectively improve the spherical effect and is used to stimulate the regeneration of collagen in the regeneration and filling field.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118206089B_ABST
    Figure CN118206089B_ABST
Patent Text Reader

Abstract

The present invention relates to the technical field of biomedical materials, and in particular to a hydroxyapatite microsphere and a preparation method and application thereof, wherein the preparation method comprises the following steps: S1, dissolving a chelating agent, a calcium source, a phosphorus source, and urea in water to obtain a reaction solution; wherein the chelating agent comprises: one or more of glutamic acid, glutamate, aspartic acid, and aspartate, and one or more of disodium ethylenediaminetetraacetic acid and sodium citrate; S2, adjusting the pH value of the reaction solution to 1.00-4.00; S3, transferring the pH-adjusted reaction solution to a hydrothermal reactor, and placing it at a temperature of 90-250°C for reaction; S4, after the reaction is completed, collecting the precipitate and washing it to neutrality, and drying it to obtain hydroxyapatite microspheres. The method of the present invention can prepare porous hydroxyapatite microspheres with adjustable morphology, which are used in the field of regenerative filling materials and can well stimulate the regeneration of collagen.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biomedical materials, and in particular to hydroxyapatite microspheres and a preparation method and application thereof. Background Art

[0002] Hydroxyapatite (HAP) is the main inorganic component of human hard tissue. In the field of biomedical materials, it is widely used in bone implants, wound repair, regeneration and filling, drug delivery and other fields. Designing HAP with different morphological and structural characteristics according to the needs of different fields is of great significance for exerting its functions. Porous HAP microspheres can improve the adsorption characteristics of materials and the interaction between materials and proteins and cells, improve the immune regulation of materials, etc. due to their unique porous structure and high specific surface area. Therefore, it is of great significance to develop HAP microsphere materials with specific porous morphological structures.

[0003] Methods for preparing porous HAP microspheres include spray drying, emulsion, hydrothermal synthesis, and the like. Although porous HAP microspheres can be obtained by both spray drying and emulsion, their preparation methods are relatively complicated. For example, the spray drying method requires synthesis, collection, washing, drying, crushing and grinding, slurry preparation, spraying, drying, sintering, and the like. At the same time, the spray slurry needs to be adjusted according to the different morphologies of the microspheres, and the process is also complicated; the emulsion method has a similar process to the spray drying method for preparing HAP microspheres, and requires a large amount of organic oil phase reagents. For microspheres with different morphologies, the HAP dispersed phase also needs to be adjusted. At the same time, these two preparation methods are difficult to obtain HAP microspheres with nano self-assembled structures. Compared with these two preparation methods, the hydrothermal synthesis method has a simple preparation process and is easy to achieve a nano assembly structure. In addition, the HAP microspheres prepared by the hydrothermal method are more similar to the composition of natural HAP. Although there are many reports that HAP microspheres with a certain particle size can be obtained by hydrothermal synthesis, these methods are difficult to obtain HAP microspheres with continuously controllable particle size, and it is still difficult to adjust the pore structure of HAP microspheres. Therefore, the development of a new hydrothermal synthesis process to obtain a preparation method for HAP microspheres with controllable and adjustable structure is still an urgent problem to be solved.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] The purpose of the present invention is to provide a hydroxyapatite microsphere and a preparation method and application thereof. The method can prepare porous hydroxyapatite microspheres with controllable morphology.

[0006] The first aspect of the present invention provides a method for preparing hydroxyapatite microspheres, comprising the following steps:

[0007] S1, dissolving a chelating agent, a calcium source, a phosphorus source, and urea in water to obtain a reaction solution;

[0008] Wherein, the chelating agent includes: one or more of glutamic acid, glutamate, aspartic acid, aspartate, and one or more of disodium ethylenediaminetetraacetate and sodium citrate;

[0009] S2. Adjust the pH value of the reaction solution to 1.00-4.00;

[0010] S3, transferring the pH-adjusted reaction solution to a hydrothermal reactor and reacting at a temperature of 90 to 250° C.;

[0011] S4. After the reaction is completed, the precipitate is collected and washed to neutrality, and then dried to obtain hydroxyapatite microspheres.

[0012] Preferably, in step S1, the chelating agent is dissolved in deionized water, and then a calcium source, a phosphorus source and urea are added in sequence.

[0013] Preferably, in step S1, the chelating agent is any one of the following components:

[0014] (Ⅰ) Glutamic acid and disodium edetate;

[0015] (II) Glutamate and disodium EDTA;

[0016] (III) glutamic acid and sodium citrate;

[0017] (IV) glutamate and sodium citrate;

[0018] (V) aspartic acid and disodium edetate;

[0019] (VI) Aspartate and disodium edetate;

[0020] (VII) aspartic acid and sodium citrate;

[0021] (VIII) Aspartate and sodium citrate.

[0022] Preferably, the molar ratio of the two chelating agents in any one of groups (I) to (VIII) is (1.0-1.5):(0.0-0.3).

[0023] In a specific embodiment, the particle size and pore size of the hydroxyapatite microspheres can be effectively reduced by increasing the proportion of disodium ethylenediaminetetraacetic acid or sodium citrate.

[0024] Preferably, in step S1, the molar ratio of the chelating agent to the calcium source is (1.4-2.0):1.

[0025] Preferably, in step S1, the molar ratio of the calcium source to the phosphorus source is (1.2-2.0):1.

[0026] Preferably, in step S1, the molar ratio of urea to calcium source is (0.67-1.67): (0.02-0.22).

[0027] In a specific embodiment, by increasing the urea concentration, the particle size of the hydroxyapatite microspheres can be reduced from 70 μm to 5 μm, and the pore size can be reduced from 2 μm to 0.1 μm.

[0028] Preferably, in step S1, the calcium source is a soluble calcium salt, and the phosphorus source is a soluble phosphate.

[0029] Preferably, the soluble calcium salt includes one or more of Ca(NO3)2·4H2O, CaCl2·2H2O, and CaCl2, and the soluble phosphate includes one or more of (NH4)2HPO4, (NH4)H2PO4, Na2HPO4, NaH2PO4, K2HPO4, and KH2PO4.

[0030] Preferably, in step S1, the molar concentration of the calcium source is 0.02-0.22 mol / L, the molar concentration of the phosphorus source is 0.02-0.11 mol / L, and the molar concentration of the urea is 0.67-1.67 mol / L.

[0031] Preferably, in step S2, the acid used to adjust the pH is one or more of nitric acid, hydrochloric acid or sulfuric acid, and the base used is one or more of ammonia water or caustic soda solution; more preferably, the acid used to adjust the pH is nitric acid, and the base used is ammonia water.

[0032] Preferably, in step S3, the reaction temperature is 160-190° C., and the reaction time is between 1 and 10 h; more preferably, the reaction temperature is 180° C., and the reaction time is 2 h.

[0033] In a specific embodiment, the sphering effect can be effectively improved by controlling the reaction temperature and reaction time.

[0034] Preferably, in step S4, drying is performed in an oven at 80° C. to a constant weight.

[0035] The second aspect of the present invention provides hydroxyapatite microspheres, which are prepared by the above preparation method.

[0036] The third aspect of the present invention provides the use of the above-mentioned hydroxyapatite microspheres in the field of regeneration and filling.

[0037] Preferably, the hydroxyapatite microspheres are implanted subcutaneously together with hyaluronic acid gel.

[0038] Specifically, the hydroxyapatite microspheres are mixed with hyaluronic acid gel and injected subcutaneously.

[0039] A fourth aspect of the present invention provides a regenerative filling material, comprising: the above-mentioned hydroxyapatite microspheres and hyaluronic acid.

[0040] Preferably, the mass ratio of the hydroxyapatite microspheres to the hyaluronic acid gel is (10-56):(10-25); more preferably 35:18.

[0041] The present invention has the following beneficial effects:

[0042] (1) The method of the present invention uses a specific type of chelating agent and controls the proportion of the chelating agent to adjust the particle size and pore size of the hydroxyapatite microspheres;

[0043] (2) The method of the present invention can adjust the particle size and pore size of hydroxyapatite microspheres by adjusting the ratio of the reactants;

[0044] (3) The method of the present invention can effectively improve the ball-forming effect by adjusting the reaction temperature and reaction time;

[0045] (4) The method of the present invention can realize the preparation of porous hydroxyapatite microspheres with different morphologies and structures;

[0046] (5) The hydroxyapatite microspheres prepared by the present invention are used in the field of regenerative filling materials and can well stimulate the regeneration of collagen. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0048] Figure 1 This is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 1 of the present invention;

[0049] Figure 2 This is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 2 of the present invention;

[0050] Figure 3 This is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 3 of the present invention;

[0051] Figure 4A ~C is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 4 of the present invention;

[0052] Figure 5A This is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 5 of the present invention;

[0053] Figure 5B This is a scanning electron microscope image of the hydroxyapatite microspheres prepared in Example 5 of the present invention;

[0054] Fig. 6A This is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 6 of the present invention;

[0055] Figure 6B This is a scanning electron microscope image of the hydroxyapatite microspheres prepared in Example 6 of the present invention;

[0056] Figure 6C This is the X-ray diffraction pattern of the hydroxyapatite microspheres prepared in Example 6 of the present invention;

[0057] Fig.6D This is a particle size distribution diagram of hydroxyapatite microspheres prepared in Example 6 of the present invention;

[0058] Fig. 7A This is an optical microscopic image of the hydroxyapatite microspheres prepared in Example 7 of the present invention;

[0059] Figure 7B This is a scanning electron microscope image of the hydroxyapatite microspheres prepared in Example 7 of the present invention;

[0060] Figure 7C This is the X-ray diffraction pattern of the hydroxyapatite microspheres prepared in Example 7 of the present invention;

[0061] Fig.7D This is a particle size distribution diagram of hydroxyapatite microspheres prepared in Example 7 of the present invention;

[0062] Fig. 8A The Masson staining result after 4 weeks of subcutaneous implantation provided in Example 8 of the present invention;

[0063] Figure 8B This is the H&E staining result provided in Example 8 of the present invention after 4 weeks of subcutaneous implantation. DETAILED DESCRIPTION

[0064] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.

[0065] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form also includes the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0066] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0067] Example 1

[0068] This embodiment provides a method for preparing hydroxyapatite microspheres, comprising the following steps:

[0069] S1. Dissolve 0.5297 g of glutamic acid in 60 mL of deionized water, and then add 0.2877 g of calcium chloride, 0.205 g of diammonium hydrogen phosphate and 3.00 g of urea in sequence to obtain a reaction solution;

[0070] S2, adjusting the pH of the reaction solution to 1.00-4.00 with HNO3 / ammonia water;

[0071] S3, the reaction solution after pH adjustment was stirred for 30 min, then transferred to a hydrothermal reactor, and placed in a forced air drying oven heated to 160° C. for 2 h, and then naturally cooled to room temperature after the reaction was completed;

[0072] S4. Filter and collect the precipitated product, and repeatedly wash the product with purified water until the product is neutral, and then dry it in an oven at 80° C. to constant weight to obtain hydroxyapatite microspheres.

[0073] The optical microscopic image of the hydroxyapatite microspheres prepared in this example is as follows: Figure 1 As shown in the figure, it can be seen that the particles collected after the reaction have a certain non-spherical cluster structure.

[0074] Example 2

[0075] In this embodiment, the reaction temperature of step S3 in embodiment 1 is changed to 180° C., and the remaining operation steps are the same as those in embodiment 1.

[0076] The optical microscopic image of the hydroxyapatite microspheres prepared in this example is as follows: Figure 2As shown in the figure, it can be seen that compared with Example 1, under the same reaction time conditions, increasing the reaction temperature can improve the balling effect.

[0077] Example 3

[0078] In this embodiment, the reaction temperature of step S3 in embodiment 1 is changed to 190° C., and the remaining operation steps are the same as those in embodiment 1.

[0079] The optical microscopic image of the hydroxyapatite microspheres prepared in this example is as follows: Figure 3 As shown in the figure, it can be seen that compared with Example 2, under the same reaction time conditions, further increasing the reaction temperature will lead to an increase in the number of unspherical cluster structures, indicating that the reaction temperature and time have an impact on particle formation.

[0080] Example 4

[0081] The reaction conditions of this embodiment are the same as those of embodiment 2, except that 160 mg / 500 mg / 1000 mg of disodium ethylenediaminetetraacetate are added in step S1, respectively, and the remaining operation steps are the same as those of embodiment 2.

[0082] The optical microscopic image of the hydroxyapatite microspheres prepared in this example is as follows: Figure 4A As shown in Figure ~C, it can be seen from the figure that the particle size decreases with the increase of disodium EDTA content.

[0083] Example 5

[0084] S1. Dissolve 1.0594 g of glutamic acid in 60 mL of deionized water, and then add 0.5754 g of calcium chloride, 0.4098 g of diammonium hydrogen phosphate, 3.60 g of urea and 160 mg of disodium ethylenediaminetetraacetate in sequence to obtain a reaction solution;

[0085] S2, adjusting the pH of the reaction solution to 1.00-4.00 with HNO3 / ammonia water;

[0086] S3, the reaction solution after pH adjustment was stirred for 30 min, then transferred to a hydrothermal reactor, and placed in a forced air drying oven heated to 180° C. for 2 h, and then naturally cooled to room temperature after the reaction was completed;

[0087] S4. Filter and collect the precipitated product, and repeatedly wash the product with purified water until the product is neutral, and then dry it in an oven at 80° C. to constant weight to obtain hydroxyapatite microspheres.

[0088] The optical microscopic image and scanning electron microscopic image of the hydroxyapatite microspheres prepared in this example are shown in FIG. Figure 5A As shown in Figure 1B, it can be seen from the figure that compared with Example 4, the pore size of the microspheres decreases as the concentration of the reactants increases.

[0089] Example 6

[0090] S1. Dissolve 2.2461 g of glutamic acid hydrochloride in 60 mL of deionized water, and then sequentially add 1.264 g of calcium chloride, 0.900 g of diammonium hydrogen phosphate, 3.60 g of urea and 160 mg of disodium ethylenediaminetetraacetate to obtain a reaction solution;

[0091] S2, adjusting the pH of the reaction solution to 1.00-4.00 with HNO3 / ammonia water;

[0092] S3, the reaction solution after pH adjustment was stirred for 30 min, then transferred to a hydrothermal reactor, and placed in a forced air drying oven heated to 180° C. for 2 h, and then naturally cooled to room temperature after the reaction was completed;

[0093] S4. Filter and collect the precipitated product, and repeatedly wash the product with purified water until the product is neutral, and then dry it in an oven at 80° C. to constant weight to obtain hydroxyapatite microspheres.

[0094] The optical microscopic image and scanning electron microscopic image of the hydroxyapatite microspheres prepared in this example are shown in FIG. Fig. 6A As shown in Figure 4B, it can be seen from the figure that compared with Example 5, the pore size of the microspheres is further reduced by further increasing the concentration of the reactants.

[0095] The X-ray diffraction pattern of the hydroxyapatite microspheres prepared in this example is as follows: Figure 6C As shown in the figure, it can be seen that the XRD diffraction characteristic peaks of the obtained microspheres correspond one to one with those of HAP, indicating that the synthesized microspheres are typical HAP phase materials.

[0096] The particle size distribution of the hydroxyapatite microspheres prepared in this example is shown in Fig.6D As shown in the figure, it can be seen that the particle size distribution is normally distributed, and 10-45um microspheres account for about 82%.

[0097] Example 7

[0098] S1. Dissolve 2.2461 g of glutamic acid hydrochloride in 60 mL of deionized water, and then add 1.264 g of calcium chloride, 0.900 g of diammonium hydrogen phosphate, 3.60 g of urea and 1600 mg of disodium ethylenediaminetetraacetate in sequence to obtain a reaction solution;

[0099] S2, adjusting the pH of the reaction solution to 1.00-4.00 with HNO3 / ammonia water;

[0100] S3, the reaction solution after pH adjustment was stirred for 30 min, then transferred to a hydrothermal reactor, and placed in a forced air drying oven heated to 180° C. for 2 h, and then naturally cooled to room temperature after the reaction was completed;

[0101] S4. Filter and collect the precipitated product, and repeatedly wash the product with purified water until the product is neutral, and then dry it in an oven at 80° C. to constant weight to obtain hydroxyapatite microspheres.

[0102] The optical microscopic image and scanning electron microscopic image of the hydroxyapatite microspheres prepared in this example are as follows: Fig. 7A As shown in Figure 1-B, it can be seen from the figure that compared with Example 6, increasing the concentration of disodium ethylenediaminetetraacetic acid reduces the pore size of the microspheres.

[0103] The X-ray diffraction pattern of the hydroxyapatite microspheres prepared in this example is as follows: Figure 7C As shown in the figure, it can be seen that the XRD diffraction characteristic peaks of the obtained microspheres correspond one to one with those of HAP, indicating that the synthesized microspheres are typical HAP phase materials.

[0104] The particle size distribution of the hydroxyapatite microspheres prepared in this example is shown in Fig.7D As shown in the figure, it can be seen that the particle size distribution is normally distributed, and 2-20um microspheres account for about 96%.

[0105] Example 8

[0106] The hydroxyapatite microspheres prepared in Example 6 were mixed with hyaluronic acid gel at a mass ratio of 35:18 and injected subcutaneously into rats. Samples were taken out at 4 weeks and sectioned for staining.

[0107] Masson staining results Fig. 8A As shown, it can be seen from the figure: collagen deposition increases.

[0108] H&E staining results Figure 8B As shown, it can be seen from the figure: the local cells increase.

[0109] The above results show that the porous hydroxyapatite microspheres prepared by the present invention in combination with hyaluronic acid gel can well stimulate the regeneration of collagen.

[0110] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for preparing hydroxyapatite microspheres, characterized in that: The steps include: S1, dissolving a chelating agent, a calcium source, a phosphorus source, and urea in water to obtain a reaction solution; Wherein, the chelating agent is any one of the following components: (Ⅰ) Glutamic acid and disodium edetate; (II) Glutamate and disodium EDTA; (III) glutamic acid and sodium citrate; (IV) glutamate and sodium citrate; (V) aspartic acid and disodium edetate; (VI) Aspartate and disodium edetate; (VII) aspartic acid and sodium citrate; (VIII) Aspartate and sodium citrate S2. Adjust the pH value of the reaction solution to 1.00-4.00; S3, transferring the pH-adjusted reaction solution to a hydrothermal reactor and reacting at a temperature of 90 to 250° C.; S4. After the reaction is completed, the precipitate is collected and washed to neutrality, and then dried to obtain hydroxyapatite microspheres.

2. The method for preparing hydroxyapatite microspheres according to claim 1, characterized in that: In step S1, the molar ratio of the calcium source to the phosphorus source is (1.2-2):

1.

3. The method for preparing hydroxyapatite microspheres according to claim 1, characterized in that: In step S1, the calcium source is a soluble calcium salt, and the phosphorus source is a soluble phosphate.

4. The method for preparing hydroxyapatite microspheres according to claim 3, characterized in that: The soluble calcium salt includes one or more of Ca(NO3)2·4H2O, CaCl2·2H2O, and CaCl2; the soluble phosphate includes one or more of (NH4)2HPO4, (NH4)H2PO4, Na2HPO4, NaH2PO4, K2HPO4, and KH2PO4.

5. The method for preparing hydroxyapatite microspheres according to claim 1, characterized in that: In step S1, the molar concentration of the calcium source is 0.02-0.22 mol / L, the molar concentration of the phosphorus source is 0.02-0.11 mol / L, and the molar concentration of the urea is 0.67-1.67 mol / L.

6. The method for preparing hydroxyapatite microspheres according to claim 1, characterized in that: In step S2, the acid used to adjust the pH is one or more of nitric acid, hydrochloric acid or sulfuric acid, and the base used is one or more of ammonia water or caustic soda solution.

7. A hydroxyapatite microsphere, characterized in that: The method is prepared by the preparation method according to any one of claims 1 to 6.

8. The use of the hydroxyapatite microspheres according to claim 7 in the field of regenerated filling materials, characterized in that: The hydroxyapatite microspheres are implanted subcutaneously together with the hyaluronic acid gel.

9. A recycled filling material, characterized in that: include: The hydroxyapatite microspheres and hyaluronic acid gel according to claim 7.

Citation Information

Cited By

  • Hydroxyapatite microspheres and method for preparing same with controllable particle size and applications

    CN123002792A